Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies

Haileyesus Getahun, Wanitchaya Kittikraisak, Charles M Heilig, Elizabeth L Corbett, Helen Ayles, Kevin P Cain, Alison D Grant, Gavin J Churchyard, Michael Kimerling, Sarita Shah, Stephen D Lawn, Robin Wood, Gary Maartens, Reuben Granich, Anand A Date, Jay K Varma, Haileyesus Getahun, Wanitchaya Kittikraisak, Charles M Heilig, Elizabeth L Corbett, Helen Ayles, Kevin P Cain, Alison D Grant, Gavin J Churchyard, Michael Kimerling, Sarita Shah, Stephen D Lawn, Robin Wood, Gary Maartens, Reuben Granich, Anand A Date, Jay K Varma

Abstract

Background: The World Health Organization recommends the screening of all people living with HIV for tuberculosis (TB) disease, followed by TB treatment, or isoniazid preventive therapy (IPT) when TB is excluded. However, the difficulty of reliably excluding TB disease has severely limited TB screening and IPT uptake in resource-limited settings. We conducted an individual participant data meta-analysis of primary studies, aiming to identify a sensitive TB screening rule.

Methods and findings: We identified 12 studies that had systematically collected sputum specimens regardless of signs or symptoms, at least one mycobacterial culture, clinical symptoms, and HIV and TB disease status. Bivariate random-effects meta-analysis and the hierarchical summary relative operating characteristic curves were used to evaluate the screening performance of all combinations of variables of interest. TB disease was diagnosed in 557 (5.8%) of 9,626 people living with HIV. The primary analysis included 8,148 people living with HIV who could be evaluated on five symptoms from nine of the 12 studies. The median age was 34 years. The best performing rule was the presence of any one of: current cough (any duration), fever, night sweats, or weight loss. The overall sensitivity of this rule was 78.9% (95% confidence interval [CI] 58.3%-90.9%) and specificity was 49.6% (95% CI 29.2%-70.1%). Its sensitivity increased to 90.1% (95% CI 76.3%-96.2%) among participants selected from clinical settings and to 88.0% (95% CI 76.1%-94.4%) among those who were not previously screened for TB. Negative predictive value was 97.7% (95% CI 97.4%-98.0%) and 90.0% (95% CI 88.6%-91.3%) at 5% and 20% prevalence of TB among people living with HIV, respectively. Abnormal chest radiographic findings increased the sensitivity of the rule by 11.7% (90.6% versus 78.9%) with a reduction of specificity by 10.7% (49.6% versus 38.9%).

Conclusions: Absence of all of current cough, fever, night sweats, and weight loss can identify a subset of people living with HIV who have a very low probability of having TB disease. A simplified screening rule using any one of these symptoms can be used in resource-constrained settings to identify people living with HIV in need of further diagnostic assessment for TB. Use of this algorithm should result in earlier TB diagnosis and treatment, and should allow for substantial scale-up of IPT.

Conflict of interest statement

HG and RG are staff members of the World Health Organization. The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of the World Health Organization.

Figures

Figure 1. Search strategy and studies included…
Figure 1. Search strategy and studies included in the meta-analysis (PRISMA flow diagram).
Figure 2. Flow chart of study participants…
Figure 2. Flow chart of study participants included in the individual patient data meta-analysis.
Figure 3. Diagnostic performance of CFSW rule…
Figure 3. Diagnostic performance of CFSW rule in the included studies.
BREMA, bivariate random-effects meta-analysis; HSROC, hierarchical summary relative operating characteristic.
Figure 4. Algorithm for TB screening in…
Figure 4. Algorithm for TB screening in person living with HIV in HIV prevalent and resource-constrained settings.
* Every person living with HIV needs to be evaluated for ART eligibility, and all settings providing care should reduce TB transmission through proper measures. ** Chest radiography is not required to classify patients into the TB and not-TB groups, but can be done, if available, to increase the sensitivity of screening. *** Assess for contraindications, including active hepatitis (acute or chronic), regular and heavy alcohol consumption, and symptoms of peripheral neuropathy, is required prior to initiating IPT. Past history of TB is not a contraindication for starting IPT. Tuberculin skin test may be performed as part of eligibility screening in some settings. **** Investigations for TB should be done in accordance with existing national guidelines.

References

    1. Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010;50:S201–207.
    1. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, et al. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis. 2005;191:150–158.
    1. Havlir DV, Getahun H, Sanne I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA. 2008;300:423–430.
    1. Mukadi YD, Wiktor SZ, Coulibaly IM, Coulibaly D, Mbengue A, et al. Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Cote d'Ivoire. Aids. 1997;11:1151–1158.
    1. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr. 2006;43:42–46.
    1. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. Aids. 2005;19:2141–2148.
    1. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575–1580.
    1. Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis. 2007;196(Suppl 1):S86–107.
    1. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002;359:2059–2064.
    1. Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, et al. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001. PLoS ONE. 2007;2:e826. doi: .
    1. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. Aids. 2006;20:1605–1612.
    1. Burgess AL, Fitzgerald DW, Severe P, Joseph P, Noel E, et al. Integration of tuberculosis screening at an HIV voluntary counselling and testing centre in Haiti. Aids. 2001;15:1875–1879.
    1. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010:CD000171.
    1. WHO. Interim policy on collaborative TB/HIV activities, World Health Organization. 2004 Geneva: WHO. WHO/HTM/TB/2004.330 WHO/HTM/HIV/2004.1. 2004.
    1. WHO. Global tuberculosis control report: World Health Organization. Geneva: WHO. WHO/HTM/TB/ 2010;2010.7
    1. Reid MJ, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis. 2009;9:173–184.
    1. Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007;369:2042–2049.
    1. Ayles H, Schaap A, Nota A, Sismanidis C, Tembwe R, et al. Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. PLoS One. 2009;4:e5602. doi: .
    1. Corbett EL, Zezai A, Cheung YB, Bandason T, Dauya E, et al. Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ. 2010;88:13–21.
    1. Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, et al. An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med. 2010;362:707–716.
    1. Day JH, Charalambous S, Fielding KL, Hayes RJ, Churchyard GJ, et al. Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. Int J Tuberc Lung Dis. 2006;10:523–529.
    1. Corbett EL, Bandason T, Cheung YB, Munyati S, Godfrey-Faussett P, et al. Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med. 2007;4:e22. doi: .
    1. Lewis JJ, Charalambous S, Day JH, Fielding KL, Grant AD, et al. HIV infection does not affect active case finding of tuberculosis in South African gold miners. Am J Respir Crit Care Med. 2009;180:1271–1278.
    1. Shah S, Demissie M, Lambert L, Ahmed J, Leulseged S, et al. Intensified tuberculosis case finding among HIV-Infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr. 2009;50:537–545.
    1. Kimerling ME, Schuchter J, Chanthol E, Kunthy T, Stuer F, et al. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int J Tuberc Lung Dis. 2002;6:988–994.
    1. Lawn S, Edwards D, Kranzer K, Vogt M, Bekker L, et al. Urine lipoarabinomannan assay for tuberculosis screening prior to antiretroviral therapy: diagnostic yield and association with immune reconstitution disease. AIDS. 2009;23:1875–1880.
    1. Wood R, Middelkoop K, Myer L, Grant AD, Whitelaw A, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med. 2007;175:87–93.
    1. Mohammed A, Ehrlich R, Wood R, Cilliers F, Maartens G. Screening for tuberculosis in adults with advanced HIV infection prior to preventive therapy. Int J Tuberc Lung Dis. 2004;8:792–795.
    1. Chheng P, Tamhane A, Natpratan C, Tan V, Lay V, et al. Pulmonary tuberculosis among patients visiting a voluntary confidential counseling and testing center, Cambodia. Int J Tuberc Lung Dis. 2008;12:54–62.
    1. Bassett IV, Wang B, Chetty S, Giddy J, Losina E, et al. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis. 2010;51:823–829.
    1. Cruciani M, Scarparo C, Malena M, Bosco O, Serpelloni G, et al. Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol. 2004;42:2321–2325.
    1. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics. 2007;8:239–251.
    1. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58:982–990.
    1. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet. 2005;365:1500–1505.
    1. Reilly B, Evans A. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. An Intern Med. 2006;144:210–212.
    1. WHO. Compendium of indicators for monitoring and evaluating national tuberculosis programs. 2004 WHO/HTM/TB/2004.344. Geneva: WHO.
    1. Mosimaneotsile B, Talbot EA, Moeti TL, Hone NM, Moalosi G, et al. Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana. Lancet. 2003;362:1551–1552.
    1. Samandari TAT, Arwady A, Yoon J, Nyirenda S, et al. Asymptomatic pulmonary TB among HIV-infected adults screened for the Botswana isoniazid preventive therapy clinical trial, 2004-2006 [Abstract 862]. 2007 In: Proceedings of the 14th Conference on Retroviruses and Opportunistic Infections; 25-28 February 2007; Los Angeles, California, United States.
    1. Kranzer K, Houben RM, Glynn JR, Bekker LG, Wood R, et al. Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:93–102.
    1. Lawn SD, Wood R, De Cock KM, Kranzer K, Lewis JJ, et al. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis. 2010;10:489–498.
    1. Banerji D, Andersen S. A sociological study of awareness of symptoms among persons with pulmonary tuberculosis. Bull World Health Organ. 1963;29:665–683.
    1. WHO. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents: recommendations for HIV-prevalent and resource-constrained settings. 2007 WHO/HTM/TB/2007.376 WHO/HIV/2007.01. Geneva: WHO.

Source: PubMed

3
Abonnieren